Executive VP, Discovery and Bioinformatics

Herve Rhinn is our Executive Vice President of Discovery & Bioinformatics. Herve was previously in charge of Bioinformatics and Discovery at Prevail Therapeutics and, prior to that, led the Target Discovery, Functional Genomics and Immuno-Neurology groups at Alector. He spent 10 years at Columbia University, in Asa Abeliovich’s lab, holding an Assistant Professor position in the Pathology Department. There he worked on generating and integrating large-scale omics datasets to elucidate the effect of the disease-associated genetic variants in neurodegenerative disorders and developed innovative analysis methods that identified genetic determinants of human brain aging. Prior to this, he worked in Daniel Scherman’s lab on non-viral gene therapy for CNS lysosomal storage disorders and on traumatic brain injury and cerebral ischemia models. An engineer by training (Master of Engineering, Ecole Polytechnique, France) he holds a Ph.D. in Biology (Pierre and Marie Curie / Sorbonne University, Paris, France).